Continuous Glucose Monitoring (CGM) Systems/Devices Market Surpass $2.2 Billion By 2026 | CAGR 14.3%

Author: Acumen Research and Consulting

The global Continuous Glucose Monitoring (CGM) Systems/Devices market size is anticipated to around USD 2.2 billion by 2026, this market is anticipated to grow with 14.3% CAGR during the forecast time period.

Developing instances of diabetes, combined with expanding adoption of continuous glucose monitoring (CGM) gadgets, has been driving the market. CGM frameworks are insignificantly obtrusive and offer a simple and compelling approach to manage diabetes. They can likewise recognize radical changes in blood glucose level, in this way avoiding hypoglycaemic conditions.

These gadgets encourage examination of blood glucose levels at various time interims with the assistance of a sensor. Individual readings nourished into to a diabetes the board programming through a remote system enable patients to comprehend the disease better, subsequently helping them to oversee it in a progressively powerful manner.

Download Report Sample Pages For Better Understanding@ 

Smoking, weight, physical inertia, and hypertension and elevated cholesterol are the basic hazard factors related with diabetes intricacies. As per the information distributed in National Diabetes Statistics Report 2017 by Centers for Disease Control and Prevention (CDC) show diabetes as the seventh driving reason for death in U.S.

It additionally furnishes patients with bits of knowledge about food consumption, medicine, physical activities exercises, and sicknesses. The coming of computerized therapeutics has additionally supported CGM gadget producers to contact diabetic patients. Different applications are accessible in the market that coordinate information gathered from CGM gadgets for future pattern investigation and resulting changes to be made in the patient's way of life. Every one of these components are relied upon to positively affect the market development.

The global Continuous Glucose Monitoring (CGM) Systems/Devices market is segmented into component, end-user, and region.On the basis of component, the global Continuous Glucose Monitoring (CGM) Systems/Devices market is segmented into transmitters & receivers, sensors, and insulin pumps. On the basis of end-user, the global Continuous Glucose Monitoring (CGM) Systems/Devices market is segmented into hospitals, home care settings, and others. On the basis of region the global Continuous Glucose Monitoring (CGM) Systems/Devices market is bifurcated into Europe, Latin America, North America, Middle East & Africa, and Asia Pacific.

The North American district is relied upon to lead the worldwide market. Expanding instances of diabetes and endeavours taken by the national government to deal with the disease at a bigger dimension are required to drive the area's development. Rising adoption of exchange and novel gadgets have been seen in the area, accelerating market development.

Preventive measures taken by the government to enable diabetic people to comprehend and deal with the illness before genuine results happen are the key driver for the regional market. The locale is relied upon to prosper attributable to technological advancements and considerable research and development in diabetes care.


Asia Pacific locale is foreseen to witness the most noteworthy CAGR during the forthcoming years. As per the Asian Diabetes Prevention Initiative, practically 60% of the world's diabetic populace resides in the Asia Pacific region. High commonness of the infection in emerging nations, for example, India and China has been pushing market development in the region. Additionally, rising healthcare expenditure, expanding investment and venture by organizations, and good regulatory approaches are likewise emphatically influencing the market development in this region.

Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. And also, growing R&D investments paired with technical advancements to commercialize highly efficient products are expected to offer huge growth opportunities for industry participants. Some of the main businesses present in the Continuous Glucose Monitoring (CGM) Systems/Devices market are GlySens, Pfizer Inc.,Ypsomed, Baxter International Inc., Novo Nordisk,

Abbott Laboratories, Animas Corporation, and Medtronic, Inc. Significant strategic initiatives undertaken by global businesses include partnerships, new product launch, acquisitions.

Organizations are additionally progressively growing new products, which has additionally supported in the development of their current portfolio with progressive technologies. For example, in February, 2016 Animas Corporation declared the dispatch of Animas Academy in the Ireland and U.K., which is an instructive program for people managing diabetes with an insulin pump and strengthening innovation related with it.


The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report - 

Would like to place an order or any question, please feel free to contact at | +1 407 915 4157